ARCHIVES

FDA Promises No More IND Disruptions Without “Very Valid Reasons,” Nears Agreement With NCI

This article is from The Cancer Letter archive.

Vol. 03 No. 15 | April 15, 1977

Download PDF Visit The Full Archive

Related Articles

GAO Recommends Tighter Policies on NIH Recusals.

June 29, 2007

Chemoprevention Concept Approved By DCPC Bard Uses Biological Markers To Assess Risk Modulation

September 27, 1985

Robert Day Named New Director At Hutchinson Center

June 19, 1981

Techniques Developing Out Of Virus research Leading To Improved Therapy, Early Diagnosis

March 4, 1977

NCI Commits $8 Million More to R01s, Increases Payline to 12th Percentile. Surgeon General’s Report Says There’s No Safe Level of Secondhand Smoke.

June 30, 2006

Double Trouble For NIH: Democrats Offer Small Increases, Bush May Veto The Bill.

July 6, 2007